12-month analysis of illuminate-a, a phase 3 study of lumasiran: sustained oxalate lowering and kidney stone event rates in primary hyperoxaluria type 1Dean Assimos,Jeffrey M. Saland,Jaap Groothoff,Yaacov Frishberg,Sally-Anne Hulton,Michael Koren,J. Scott Overcash,Anne-Laure Sellier-Leclerc,Georges Deschenes,Hadas Shasha-Lavsky,Wesley Hayes,Daniel Fuster,Daniella Magen,Shabbir H. Moochhala,Martin Coenen,Eva Simkova,Sander F. Garrelfs,David J. Sas,Kristin Meliambro,Taylor Ngo, Kenji Fujita,John M. Gansner,Tracy L. McGregor,John C. LieskeJOURNAL OF UROLOGY（2021）引用 1|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
